Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CU Healthcare Innovation Fund is a strategic healthcare-focused venture capital fund affiliated with the University of Colorado Anschutz Medical Campus. It invests in early- and growth-stage companies across digital health, therapeutics, medical devices, and diagnostics, particularly where portfolio companies can form meaningful partnerships with CU Anschutz ecosystem institutions such as UCHealth and Children's Hospital Colorado. The fund is positioned as part of the CU Anschutz innovation ecosystem and emphasizes validation, de-risking, and commercialization support rather than developing its own therapeutic pipeline. As such, it is best characterized as an active healthcare investment organization rather than an operating biotech or pharma company. The fund reports approximately $100 million-plus in assets under management across two funds and has participated in investments and exits across multiple healthcare subsectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CU Healthcare Innovation Fund.